pHase Pharmaceuticals

Manufacturing · New York, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

130 Church St Ste 109, New York City, Ne...

Phone Number

(917) 683-1240

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About pHase Pharmaceuticals

pHase Pharmaceuticals is a boutique pharma company focused on developing innovative pharmaceutical therapies, particularly a patented sublingual epinephrine formulation for treating anaphylaxis. Founded by experienced professionals with a combined 100 years in drug development, the company aims to address unmet medical needs and redefine healthcare possibilities. Their current product, P2-101, targets the 28 million individuals in the U.S. at risk of anaphylaxis, offering a more effective and convenient alternative to traditional epinephrine delivery methods. With a commitment to scientific rigor and patient safety, pHase is dedicated to advancing medical understanding and improving treatment outcomes.Explore more
pHase Pharmaceuticals's Social MediaPopular SearchesPhase Pharmaceuticals LLCpHase WebSIC Code 28,283NAICS Code 32,325Show more

pHase Pharmaceuticals Org Chart

LH
United States flag for contact location.

Chief Executive Officer

PhoneEmail
DD
United States flag for contact location.

Veterinary Assistant

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is pHase Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to pHase Pharmaceuticals

Compare insights from companies similar to pHase Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

pHase Pharmaceuticals

<$5M
11-50
Private
-
2009
$15.1M
1-10
Private
-
1987
$5.8M
11-50
Private
-
2014
<$5M
1-10
Private
-
2014
N/A
<$5M
1-10
Public
-
2007
I Richard Garr, Chief Executive Officer & General Counsel at Curative Biotechnology
I Richard GarrCEO & General Counsel
<$5M
11-50
Private
-
2019
JD
John DonelloChief Science Officer
<$5M
1-10
Private
-
2006
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

pHase Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

pHase Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about pHase Pharmaceuticals.

pHase Pharmaceuticals Tech Stack

A closer look at the technologies used by pHase Pharmaceuticals

Top Manufacturing Companies

Frequently Asked Questions Regarding pHase Pharmaceuticals

What is pHase Pharmaceuticals's official website?
pHase Pharmaceuticals's official website is www.phasepharma.com
What is pHase Pharmaceuticals's Revenue?
pHase Pharmaceuticals's revenue is <$5 Million
What is pHase Pharmaceuticals's SIC code?
pHase Pharmaceuticals's SIC: 28,283
What is pHase Pharmaceuticals's NAICS code?
pHase Pharmaceuticals's NAICS: 32,325
How many employees does pHase Pharmaceuticals have?
pHase Pharmaceuticals has 11-50 employees
What industry does pHase Pharmaceuticals belong to?
pHase Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals
What is pHase Pharmaceuticals competition?
pHase Pharmaceuticals top competitors include: Rodes, Prana Therapeutics, Gate Neurosciences, Neuronasal
What technology does pHase Pharmaceuticals use?
Some of the popular technologies that pHase Pharmaceuticals uses are: Microsoft 365, GoDaddy DNS, Starfield Technologies, GoDaddy Web Hosting
How do I contact pHase Pharmaceuticals?
pHase Pharmaceuticals contact info: Phone number: (917) 683-1240 Website: www.phasepharma.com
What does pHase Pharmaceuticals do?

pHase Pharmaceuticals is a boutique pharma company focused on developing innovative pharmaceutical therapies, particularly a patented sublingual epinephrine formulation for treating anaphylaxis. Founded by experienced professionals with a combined 100 years in drug development, the company aims to address unmet medical needs and redefine healthcare... possibilities. Their current product, P2-101, targets the 28 million individuals in the U.S. at risk of anaphylaxis, offering a more effective and convenient alternative to traditional epinephrine delivery methods. With a commitment to scientific rigor and patient safety, pHase is dedicated to advancing medical understanding and improving treatment outcomes.Read More

What are pHase Pharmaceuticals social media links?
pHase Pharmaceuticals Linkedin page
Is pHase Pharmaceuticals a public company?
pHase Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about pHase Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.